Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

Confirmed: AFib ablation more beneficial for patients with HFrEF than those with HFpEF
Researchers explored data from nearly 2,500 AFib ablation patients, sharing their findings in JAMA Cardiology.
Statin therapy may help HFpEF patients lower their risk of death, heart attack or stroke
All participants were free of ASCVD and had no history of statin use at the start of the study.
Diabetic cardiomyopathy treatment shows promise in ARISE-HF
James Januzzi Jr., MD, said the treatment's overall impact was neutral, but he and his team saw "a very clear and encouraging signal."
Keto diet ‘does not fulfill the criteria of a healthy diet,’ could be harmful for heart patients
The popular high-fat, low-carb diet is associated with multiple short-term benefits, but they appear to diminish over time.
Bayer subsidiary granted FDA’s fast track designation for new congestive heart failure treatment
AskBio, acquired by Bayer for more than $2 billion in 2020, is enrolling patients for a new clinical trial focused on the therapy's effectiveness in adult patients with non-ischemic cardiomyopathy and heart failure.

Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid

Heart failure medication may offer relief for patients with COVID-related POTS

Overall, researchers found that ivabradine was a “safe and effective” POTS treatment associated with making significant improvements to patient heart rates and quality of life.

February 17, 2021

Ablation could be ‘a powerful new strategy’ for treating heart failure patients with atrial fibrillation

According to a new study published in Circulation, ablation was associated with numerous benefits over standard drug therapy.

February 12, 2021

Hospitalizations for heart failure on the rise

Heart failure patients are also more likely to be readmitted than they were in the recent past.

February 11, 2021

Drinking coffee reduces the risk of heart failure—but not if it’s decaf

In fact, drinking decaffeinated coffee was associated with a significant increase in heart failure risk.

February 9, 2021

Sacubitril/valsartan improves self-reported quality of life for HFpEF patients

However, treatment with sacubitril/valsartan did not lead to improvements in hospitalizations for heart failure or all-cause mortality.

February 1, 2021

Heart failure hospitalizations among young adults are getting more common and more expensive

Male breast cancer patients face a heightened risk of cardiovascular issues

The new findings are part of a virtual conference being hosted by the American College of Cardiology.

January 25, 2021

Merck’s vericiguat gains FDA approval for treating high-risk chronic heart failure patients

Sold as Verquvo, the medication can help patients reduce their risk of cardiovascular death or hospitalization for heart failure.

January 22, 2021

24% of heart failure patients hospitalized with COVID-19 die

The authors examined data from more than 1.2 million patients, tracking individuals who had previously been hospitalized for heart failure and then returned later due to COVID-19.

January 21, 2021

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Heart Failure

Confirmed: AFib ablation more beneficial for patients with HFrEF than those with HFpEF

Statin therapy may help HFpEF patients lower their risk of death, heart attack or stroke

Diabetic cardiomyopathy treatment shows promise in ARISE-HF

Keto diet ‘does not fulfill the criteria of a healthy diet,’ could be harmful for heart patients

Bayer subsidiary granted FDA’s fast track designation for new congestive heart failure treatment

Around the web